Sarcomatoid mesothelioma accounts for 10% to 20% of all mesothelioma cases and is the most aggressive cell type. Asbestos causes the spindle-shaped sarcomatoid mesothelioma tumors to primarily develop in the lining of the lungs, and they are resistant to treatment.
Learn more about mesothelioma, asbestos and the steps you can take to fight this disease.
Sarcomatoid mesothelioma is a rare and aggressive asbestos-related cancer. The cancer forms when sarcomatoid cells grow into tumors. These cells are long and shaped like spindles. Tumors can develop in the lining of the lungs, abdomen, heart or testes.
Key Facts About Sarcomatoid Mesothelioma
Cell type prevalence: Sarcomatoid mesothelioma (spindle-cell mesothelioma) accounts for 10% to 20% of all cases.
Rarest cell type: About 60% of patients have the epithelial type, and 20% have the biphasic type, making sarcomatoid the least common of the three mesothelioma cell subtypes.
Treatment resistance: The fibrous nature of sarcomatoid mesothelioma cells makes them resistant to treatment, leading to a poor prognosis.
Location: Approximately 98% of sarcomatoid mesothelioma cases are pleural (lung lining), about 2% are peritoneal.
New diagnoses: Doctors diagnose approximately 300 to 600 new patients with sarcomatoid mesothelioma cell type each year.
Median survival: 15 months with immunotherapy and 10.7 months with chemotherapy.
Immunotherapy advances: Recent research has shown that immunotherapy doubles the survival rate for some patients with sarcomatoid mesothelioma.
Sarcomatoid cells grow in connective tissues, such as bones, nerves and tendons. The sarcomatoid type is the rarest of the 3 primary cell types of mesothelioma. For comparison, about 60% of patients have the epithelial type, and 20% have the biphasic type.
Sarcomatoid tumors spread easily and are tough to treat. This leads to a worse outlook for this type of mesothelioma. However, new immunotherapy treatments have helped some patients beat the odds.
What Causes Sarcomatoid Mesothelioma?
Asbestos is the main cause of sarcomatoid mesothelioma. When people breathe in asbestos fibers, these fibers build up in the body. This buildup causes irritation and inflammation. Over time, this can cause mutations that turn mesothelial cells into cancer cells.
Mesothelioma risk factors include asbestos exposure at work, in the military and from the environment. Mainly, industrial workers faced exposure. Veterans were at risk in shipyards and military bases. People were also unknowingly exposed when someone in their home took home asbestos fibers on their work clothes or body. Recently, exposure to asbestos-contaminated talc, such as in talcum powder, has led to some mesothelioma diagnoses.
Sarcomatoid mesothelioma survivor Gene Hartline worked as a sheet metal contractor, where he believes he was exposed to asbestos. He tells us, “The diagnosis was tough, especially when they said 4-6 months to live. But now, with this immunotherapy, I’m not going downhill anymore. I’m on the climb back up. And that feels good.”
What Are the Symptoms of Sarcomatoid Mesothelioma?
Common symptoms of sarcomatoid mesothelioma include shortness of breath, chest pain and persistent coughing. Severe cases can lead to breathing difficulties and a lasting cough. Symptoms may take 20 to 60 years to develop after asbestos exposure.
Symptoms depend on tumor location. Sarcomatoid cells are mainly in the lung lining. But in sarcomatoid peritoneal cancer, symptoms are different. Patients may face bowel issues, pain and swelling in the abdomen.
Symptoms of Sarcomatoid Mesothelioma
Anemia (low iron)
Chest pain or abdominal fullness
Coughing up blood
Fatigue and extreme tiredness
Lack of appetite, anorexia and nausea
Low blood oxygen levels
Persistent cough
Prolonged hoarseness
Shortness of breath
Weight loss and weakness
A 2023 review published in the journal Thoracic Cancer found sarcomatoid mesothelioma symptoms are often vague. This makes early diagnosis tough, as patients might not mention key symptoms. These symptoms are often like those of common illnesses, such as bronchitis.
If you have any mesothelioma signs or a history of asbestos exposure, speak with a specialist as soon as possible. If you have a history of asbestos exposure, speak with your doctor about early screening. An early diagnosis may mean more treatment options.
FREE MESOTHELIOMA GUIDE
Expert Guidance for Your Mesothelioma Journey
Get answers about treatment, top doctors, and financial support from the nation’s most trusted mesothelioma resource.
A pathology stain showing sarcomatoid mesothelioma cells under a microscope.
Sarcomatoid mesothelioma is diagnosed through imaging tests, biopsy and pathology analysis. Diagnosis often begins with X-rays or CT scans. If imaging reveals abnormalities, doctors collect a tissue sample for a biopsy, which is the only test that confirms cell type.
Another doctor reviews stained samples under a microscope and creates a pathology report. Pathology stains are tests that make cell features visible under a microscope. Sarcomatoid cells are long, narrow and shaped like spindles.
Your pathology report describes your tumor cell type, biomarkers and cancer stage. Your doctor uses the findings to complete your diagnosis. Ask your doctor about your report and how it affects your treatment options.
“Most patients don’t know their cell type when I initially speak with them,” says Dr. Snehal Smart, a medical doctor and Patient Advocate at The Mesothelioma Center. “I help them review their pathology report and explain what sarcomatoid cell types are and what this means for them.”
Patient Advocates can walk you through each section of the report to make sure you have a good understanding of what it explains. They can answer questions about how a diagnosis may impact treatment and prognosis.
Immunohistochemical markers, or biomarkers, can not only help diagnose you, but they can also help your doctor pick the best medication for you. For example, if sarcomatoid cells in your tumor show high PD-L1 levels (seen after staining), your doctor will likely recommend checkpoint inhibitors like Opdivo and Yervoy.
Expert Insight
Sarcomatoid mesothelioma is a rare subtype in contrast to epithelial. Sarcomatoid tends to be a little more locally progressive.
Dr. Andrea Wolf, director of the New York Mesothelioma Program at Mount Sinai
Rare Sarcomatoid Cell Types
Rare sarcomatoid mesothelioma cell subtypes can provide information about your prognosis. These types come in 3 categories. Some may provide a better prognosis. Others can point to a higher chance of metastasis.
Rare Sarcomatoid Cells
Desmoplastic mesothelioma: This sarcomatoid subtype is one of the most difficult to diagnose. With this cell type, doctors may be unable to track if your tumor is growing.
Lymphohistiocytoid mesothelioma: These tumors contain inflammatory and immune cells. This can translate to more symptoms but also a better life expectancy.
Transitional mesothelioma: This type grows and spreads like other subtypes. It consists of large, spindle-shaped cells that make the disease easier to diagnose.
These sarcomatoid mesothelioma subtypes are generally rare. They most often develop in the pleura of the lungs. Ask your physician whether there are any abnormalities in your pathology report. They can offer more information on your outlook prognosis.
What Is the Survival Rate of Sarcomatoid Mesothelioma?
A recent study showed the median survival for sarcomatoid mesothelioma was 15 months with immunotherapy and 10.7 months with chemotherapy. Each person’s prognosis differs based on health, tumor location and metastasis.
The life expectancy for sarcomatoid pleural mesothelioma cases is about 5 months. For peritoneal cases, the average is 10 to 11 months. Women with the sarcomatoid type often outlive men.
The shape of these cells makes them less likely to stick together. This means they’re more likely to spread quickly. Still, some people with sarcomatoid tumors have lived for years thanks to advances in immunotherapy.
Dr. Anna Nowak, a researcher at the Institute for Respiratory Health in Western Australia, says immunotherapy boosts survival. She tells us, “For people with sarcomatoid and biphasic mesothelioma, we can double survival with the combination of ipilimumab and nivolumab.”
Wally Rogers
Verified Asbestos.com Survivor
Immunotherapy Works Wonders for Sarcomatoid Mesothelioma Survivor
When Wally Rogers’ tumors grew after rounds of chemo, a specialist recommended Keytruda. The immunotherapy drug had an almost immediate effect. CT scans showed no sign of sarcomatoid mesothelioma after 8 months on Keytruda.
Sarcomatoid mesothelioma is treated with immunotherapy, chemotherapy, radiation and palliative care. Treatment varies for each person, depending on cancer stage, tumor size and health. The rapid recurrence of this type means surgery is rarely advised. However, it may be an option for peritoneal patients who respond well to immunotherapy.
Recent research shows immunotherapy can offer lasting benefits to some sarcomatoid patients. However, Tumor Treating Fields therapy hasn’t proven effective for sarcomatoid tumors. For the best options, it’s wise to consult a mesothelioma specialist at a top cancer center.
Sarcomatoid Mesothelioma Treatment
Chemotherapy: Patients with sarcomatoid mesothelioma who receive Alimta plus cisplatin or carboplatinchemo have a median survival of 15 months.
Immunotherapy: Opdivo and Yervoy, two immunotherapy drugs, improve patient survival an average of 4 months over chemotherapy alone.
Palliative Care: Less invasive chemo and surgery can ease symptoms and slow tumor growth. They can also improve breathing, thanks to palliative care.
Radiation Therapy: Often used alongside other therapies, radiation may increase the 2-year life expectancy 30% for some mesothelioma patients.
“Sarcomatoid mesothelioma is a little less responsive to chemotherapy,” mesothelioma specialist Dr. Andrea Wolf of Mount Sinai Hospital tells us. “But from what we see from more recent data, it may be more responsive to immunotherapy. And we have additional treatment options for those patients.”
Sarcomatoid patients may seek palliative care for symptom relief and better quality of life. Yet, only 48% of the mesothelioma patients we surveyed in 2023 reported using it.
500+ SPECIALISTS AVAILABLE
Get to the Right Doctor, Faster
Connect with top-rated doctors specializing in mesothelioma treatment, who will personalize treatment options based on your diagnosis.
Sarcomatoid mesothelioma is generally considered incurable. Surgery isn’t typically recommended for sarcomatoid mesothelioma. Other treatments including immunotherapy, chemotherapy and radiotherapy are unlikely to be curative. There may be occasional long-term survival in sarcomatoid mesothelioma treated with immunotherapies.
Answered By:Anna Nowak, internationally renowned asbestos researcher and mesothelioma advocate
Where can I get treatment for sarcomatoid cell mesothelioma?
You can get treatment for sarcomatoid mesothelioma from a specialist at a top center. This type is harder to treat and needs an expert. Specialists work at the best cancer centers, usually in major cities.
Can sarcomatoid mesothelioma be prevented?
Avoiding asbestos can help prevent sarcomatoid mesothelioma. This exposure often occurs at work or from damaged materials. Wearing personal protective gear and following guidelines can help protect you from occupational exposure. Also if you believe your home may have older legacy asbestos, hire a professional to conduct an inspection and remove it.
Is there any ongoing research on sarcomatoid mesothelioma?
Researchers are working on new treatments for sarcomatoid mesothelioma. Some participants in clinical trials have had success with new immunotherapy drugs. You might qualify for a trial and receive the latest treatment for sarcomatoid cells. So ask your mesothelioma specialist about the best options for you.
Recommended Reading
Address
1 S. Orange Ave., Suite 301, Orlando, FL 32801
Connect with us
Navigation
Monthly Newsletter
Stay up-to-date on treatment, research, clinical trials, doctors and survivors
The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our privacy policy and terms of service for more information about our website.
This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome.
The Mesothelioma Center’s claim as the most trusted resource is based on our more than 150 5-star Google and BBB reviews. Our organization also helps more than half of all mesothelioma patients annually diagnosed.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
Assisting mesothelioma patients and their loved ones since 2006.
Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
A+ rating from the Better Business Bureau.
5-star reviewed mesothelioma and support organization.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.
Asbestos.com. (2026, February 23). Sarcomatoid Mesothelioma. Retrieved March 16, 2026, from https://www.asbestos.com/mesothelioma/malignant-sarcomatoid/
MLA
"Sarcomatoid Mesothelioma." Asbestos.com, 23 Feb 2026, https://www.asbestos.com/mesothelioma/malignant-sarcomatoid/.
Chicago
Asbestos.com. "Sarcomatoid Mesothelioma." Last modified February 23, 2026. https://www.asbestos.com/mesothelioma/malignant-sarcomatoid/.
Professional Contributors Featured In This Article
We Thoroughly vet individuals who are experts in their field to contribute to articles on Asbestos.com. We believe in the integrity and quality of our educational materials, and only publish information that is relevant, factual, and backed by experts.
Dr. Jacques Fontaine is a thoracic surgeon at Moffitt Cancer Center in Tampa, Florida, where he heads up the Mesothelioma Research and Treatment Center. He specializes in minimally invasive robotic surgery and aggressive surgeries for mesothelioma.
Fact-checked and verified content:
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.